SUN PHARMACEUTICAL INDUSTRIES LTD.

NSE : SUNPHARMABSE : 524715ISIN CODE : INE044A01036Industry : Pharmaceuticals & DrugsHouse : Sun Pharma
BSE570.2028.05 (+5.17 %)
PREV CLOSE ( ) 542.15
OPEN PRICE ( ) 550.00
BID PRICE (QTY) 570.20 (16820)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2910655
TODAY'S LOW / HIGH ( )546.20 575.00
52 WK LOW / HIGH ( )433.15 728.45
NSE569.6528.2 (+5.21 %)
PREV CLOSE( ) 541.45
OPEN PRICE ( ) 550.00
BID PRICE (QTY) 569.65 (115916)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 30844893
TODAY'S LOW / HIGH( ) 546.00 575.25
52 WK LOW / HIGH ( )432.7 729.05
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 01-03 1993
Management Info
Israel Makov - Chairman Dilip S Shanghvi - Managing Director
Registered Office

Address Sun Pharma Advanced Research Centre (S P A R C),Tandalja,,
Vadodara,
Gujarat-390020

Phone 0265- 5515500 / 5515600 / 5515700

Email secretarial@sunpharma.com

Website www.sunpharma.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
NEWS
23Feb USFDA issues 3 observations for Sun Ph
The United States Food & Drug Administration (USFDA) has issued thre..
22Feb Sun Pharma recalls 17,554 bottles of n
Sun Pharmaceutical Industries’ US arm - Sun Pharmaceutical Industries In..
22Feb Sun Pharmaceutical Industries trades i
Sun Pharmaceutical Industries is currently trading at Rs. 540.60, up by..
20Feb Sun Pharma’s arm hikes stake in Ranbax
Sun Pharmaceutical Industries’ one of the wholly owned subsidiaries has..
20Feb Sun Pharma rises with arm hiking stake
Sun Pharmaceutical Industries is currently trading at Rs. 564.00, up by..
Financials
Rs. in Millions
QTR Dec 17 ANNUAL 17
Net Profit405-349.5
Gross Profit 410.4 -324.4
Operating Profit 2117.96096.8
Net Sales 20452.378067
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Dr. Reddys Lab (BSE)
 2169.25 (2.26%)
M.Cap (Rs. in Cr)35986.45
Merck (BSE)
 1486.60 (2.96%)
M.Cap (Rs. in Cr)2467.66
Abbott India (BSE)
 5788.40 (0.72%)
M.Cap (Rs. in Cr)12299.95
Zandu Realty (BSE)
 1993.80 (1.95%)
M.Cap (Rs. in Cr)160.78
Piramal Enterprises (BSE)
 2622.05 (1.31%)
M.Cap (Rs. in Cr)47275.73
Shareholding Pattern
PROMOTERS 54.38%
NON-INSTITUTION 13.48%
FI/BANKS/INSURANCE 7.43%
MUTUAL FUNDS/UTI 7.4%
GOVERNMENT 0.02%
FII 0%
ATTENTION INVESTORSKYCIPO
REGISTRATION NOS.

NSE CM-INB231215030|NSE F& O - INF231215030, NSE CD-INE231215030, BSE CM–INB011215036 |BSE F & O - INF011215036 MCX-SX CM-INB261215033|MCX-SX F & O - INF261215033|MCX-SX CD-INE261215033 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912

INVESTOR PROTECTION

Compliance officer : Aishwarya M. Kalal, Tel no: 022-40790032, Mobile no- 9773104340, E-mail id- Complaince@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.